Automation runs amok

Volume and configuration challenges are leaving companies "dumbfounded" by EDI data forms, says a report on revenue leakage in biopharma distribution channels. Among other distribution inefficiencies: chargeback and return discrepancies, and concealed shortages. The damage? Eleven billion dollars per year, or about 4 percent of industry revenue. Article Perhaps sensing an opportunity, logistics solutions provider Accellos is acquiring vSync, a maker of EDI and shipping solutions for Microsoft Dynamics. Announcement

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.